Synthetic Biology
PPAR Antagonists

PPAR Antagonists

Home / Products / Biosynthesis Chemicals / Enzyme Inhibitors / PPAR Antagonists /

PPAR Antagonists

PPAR antagonists are a class of pharmaceutical compounds that play a crucial role in regulating the activity of peroxisome proliferator-activated receptors (PPARs) These receptors are a group of nuclear hormone receptors involved in the control of various metabolic processes including lipid metabolism glucose homeostasis and inflammation PPAR antagonists inhibit the activation of PPARs which can have therapeutic implications in conditions such as diabetes dyslipidemia and cardiovascular diseases By modulating the activity of PPARs these antagonists offer potential for the development of targeted treatments that address specific metabolic disorders

Catalog Number Chemical Name CAS # Price
BC-0083 Astaxanthin 472-61-7 Online Inquiry
EI-1084 GSK-0660 1014691-61-2 Online Inquiry
EI-1114 GSK-3787 188591-46-0 Online Inquiry
EI-1146 GW-6471 880635-03-0 Online Inquiry
EI-1808 PPARγ Antagonist, G3335 36099-95-3 Online Inquiry
EI-2096 T0070907 313516-66-4 Online Inquiry
EI-2211 Trigonelline Chloride 6138-41-6 Online Inquiry


PPAR antagonists have a wide range of applications in both research and medicine In the field of research these substances are used to specifically inhibit the activity of peroxisome proliferator-activated receptors (PPARs) which play a crucial role in regulating various biological processes By blocking PPAR activity scientists can better understand the function and impact of these receptors on metabolism inflammation and other physiological pathways

In medicine PPAR antagonists have potential therapeutic applications They can be utilized in the treatment of metabolic disorders such as type 2 diabetes and dyslipidemia as PPARs are involved in the regulation of glucose and lipid metabolism By antagonizing PPARs these substances can help normalize metabolic imbalances and improve overall health

Furthermore PPAR antagonists can be explored as potential treatments for certain types of cancer Studies have shown that PPARs are involved in cancer cell proliferation differentiation and apoptosis By inhibiting PPAR activity these substances may have the ability to suppress tumor growth and enhance the efficacy of existing cancer treatments

Overall PPAR antagonists have significant implications for both research and therapeutic applications offering potential insights into various biological processes and providing novel strategies for the management of metabolic disorders and cancer

Please note that all services are for research use only. Not intended for any clinical use.

Synthetic Biology Products

Online Inquiry